| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |